Crossmark

Use of targeted therapy in cancer patients in the end-of-life period: results from an Australian centre

Crossref DOI link: https://doi.org/10.1007/s00520-016-3124-3

Published Online: 2016-02-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wann, Alysson

Ashley, David

Khasraw, Mustafa
Funding

Funding for this research was provided by:

American Society of Clinical Oncology (ASCO Merit Award in Palliative Care)
License Information

Text and Data Mining valid from 2016-02-18